BBWI241101C42000
- 0.00
- 0.000.00%
Bath & Body Works Newsroom
BofA Securities Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $45
J.P. Morgan Maintains Bath & Body Works(BBWI.US) With Hold Rating
Bath & Body Works Analyst Ratings
Baird Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $45
Telsey Advisory Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $42
BMO Capital Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $50
Buy Rating Affirmed for Bath & Body Works Amid Strategic Management Changes and Solid Financial Outlook
TD Cowen Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $40
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $51
Morgan Stanley Maintains Overweight on Bath & Body Works, Lowers Price Target to $51
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $51
Crafting a Buy Rating: Insights From Alexandra Straton's Bath & Body Works Analysis
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $38 to $56
Bath & Body Works Price Target Cut to $42.00/Share From $53.00 by Telsey Advisory Group
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $35 to $56
Bath & Body Works Is Maintained at Buy by B of A Securities
Bath & Body Works Analyst Ratings
BMO Capital Adjusts Price Target on Bath & Body Works to $50 From $52, Maintains Outperform
Bath & Body Works: Hold Rating Maintained Amid Cost-Cutting and Uncertain Sales Rebound
Barclays Remains a Hold on Bath & Body Works (BBWI)